World Journal of Hepatology - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

JOURNAL HOME

Number of total visits: 6104645

Number of visits today: 3598

Number of downloads: 3914308

PUBLISHING PARTNER

INDEXING/ABSTRACTING

MEMBERSHIP

BPG JOURNALS

Open-Access Journal

Other Issues: Previous | Next | Latest | Archive | Download full issue 3 (782)

Contents Volume 2 Issue 3 March 27, 2010

Editorial

Effect of antiviral treatment on the risk of hepatocellular carcinoma in patients with chronic hepatitis B

Konstantinos Tziomalos

World J Hepatol 2(3):91-93. Published online Mar 27, 2010. doi: 10.4254/wjh.v2.i3.91

Abstract (1098) | Core Tip (753) | Full Article (HTML) (2323) | Full Article (PDF)-515K (279) | RCA | PubMed Central | PubMed | CrossRef | Google Scholar | Times Cited (6) | Total Visits (4594) | Similar Articles (1918) | Article Quality Tracking (0) | What about the content of this article? (0) | Cite |

(0) | Open

Guidelines For Basic Science

Interactions of chemical carcinogens and genetic variation in hepatocellular carcinoma

Yu-Jing Zhang

World J Hepatol 2(3):94-102. Published online Mar 27, 2010. doi: 10.4254/wjh.v2.i3.94

Abstract (1111) | Core Tip (828) | Full Article (HTML) (3642) | Full Article (PDF)-707K (326) | RCA | PubMed Central | PubMed | CrossRef | Google Scholar | Times Cited (27) | Total Visits (6055) | Similar Articles (1750) | Article Quality Tracking (0) | What about the content of this article? (0) | Cite |

(0) | Open

Guidelines For Clinical Practice

Medical treatment of unresectable hepatocellular carcinoma: Going beyond sorafenib

Camillo Porta, Chiara Paglino

World J Hepatol 2(3):103-113. Published online Mar 27, 2010. doi: 10.4254/wjh.v2.i3.103

Abstract (1089) | Core Tip (782) | Full Article (HTML) (2825) | Figures (1-2) (397) | Tables (1-3) (384) | Full Article (PDF)-857K (316) | RCA | PubMed Central | PubMed | CrossRef | Google Scholar | Times Cited (11) | Total Visits (5986) | Similar Articles (1750) | Article Quality Tracking (0) | What about the content of this article? (0) | Cite |

(0) | Open

Review

Hepatic cancer stem cells and drug resistance: Relevance in targeted therapies for hepatocellular carcinoma

Caecilia HC Sukowati, Natalia Rosso, Lory S Crocè, Claudio Tiribelli

World J Hepatol 2(3):114-126. Published online Mar 27, 2010. doi: 10.4254/wjh.v2.i3.114

Abstract (1188) | Core Tip (782) | Full Article (HTML) (7845) | Figures (1-3) (390) | Tables (1-2) (468) | Full Article (PDF)-880K (588) | RCA | PubMed Central | PubMed | CrossRef | Google Scholar | Times Cited (37) | Total Visits (11453) | Similar Articles (1820) | Article Quality Tracking (0) | What about the content of this article? (0) | Cite |

(0) | Open

Brief Article

Proteomic analysis for developing new biomarkers of hepatocellular carcinoma

Maria Pleguezuelo, Laura M Lopez-Sanchez, Antonio Rodriguez-Ariza, Jose L Montero, Javier Briceno, Ruben Ciria, Jordi Muntane, Manuel de la Mata

World J Hepatol 2(3):127-135. Published online Mar 27, 2010. doi: 10.4254/wjh.v2.i3.127

Abstract (1187) | Core Tip (759) | Full Article (HTML) (4276) | Figures (1-4) (338) | Tables (1-2) (392) | Full Article (PDF)-862K (547) | RCA | PubMed Central | PubMed | CrossRef | Google Scholar | Times Cited (12) | Total Visits (7662) | Similar Articles (0) | Article Quality Tracking (0) | What about the content of this article? (0) | Cite |

(0) | Open

Case Report

Granulocyte colony-stimulating factor as a novel adjunct to improve hepatitis B vaccination

Sudeep Tanwar, Mark Thursz

World J Hepatol 2(3):136-138. Published online Mar 27, 2010. doi: 10.4254/wjh.v2.i3.136

Abstract (1372) | Core Tip (806) | Full Article (HTML) (2460) | Full Article (PDF)-510K (263) | RCA | PubMed Central | PubMed | CrossRef | Google Scholar | Times Cited (2) | Total Visits (5047) | Similar Articles (227) | Article Quality Tracking (0) | What about the content of this article? (0) | Cite |

(0) | Open

Write to the Help Desk

© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345